CN111135219A - Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor - Google Patents
Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor Download PDFInfo
- Publication number
- CN111135219A CN111135219A CN202010041360.1A CN202010041360A CN111135219A CN 111135219 A CN111135219 A CN 111135219A CN 202010041360 A CN202010041360 A CN 202010041360A CN 111135219 A CN111135219 A CN 111135219A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- plant stem
- eliminating
- cell composition
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 210000004027 cell Anatomy 0.000 title claims abstract description 34
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 32
- 241000196324 Embryophyta Species 0.000 title claims abstract description 30
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 21
- 208000007536 Thrombosis Diseases 0.000 title claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000759905 Camptotheca acuminata Species 0.000 claims abstract description 12
- 240000001829 Catharanthus roseus Species 0.000 claims abstract description 11
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 claims abstract description 11
- 239000006187 pill Substances 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims abstract description 9
- 239000012153 distilled water Substances 0.000 claims abstract description 7
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims abstract description 3
- 210000001519 tissue Anatomy 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 230000000877 morphologic effect Effects 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 230000012010 growth Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 claims description 2
- 238000004114 suspension culture Methods 0.000 claims description 2
- 210000003934 vacuole Anatomy 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 abstract description 17
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000007779 soft material Substances 0.000 abstract description 3
- 206010061216 Infarction Diseases 0.000 abstract description 2
- 206010042434 Sudden death Diseases 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 210000000987 immune system Anatomy 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000007574 infarction Effects 0.000 abstract description 2
- 239000000080 wetting agent Substances 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 8
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010005954 Bone development abnormal Diseases 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 230000005880 cancer cell killing Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000012830 cancer therapeutic Substances 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 125000001741 organic sulfur group Chemical group 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- -1 trichloromethionyl Chemical group 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a plant stem cell composition for dissolving thrombus and eliminating canceration cells and tumors; it adopts camptotheca acuminata, catharanthus roseus, taxus chinensis and oldenlandia diffusa fruit as raw materials to form a cambium to be induced, any one or more of the crushed materials, the extracts and the culture solution thereof is taken, starch is added to form a mixture, the mixture is uniformly stirred, ethanol or distilled water is added to be used as a wetting agent to be stirred until the mixture is completely uniform, and soft materials or drinks or granules are prepared, or the mixture is sieved by a sieve to filter out the granules, the granules are dried and then added with sodium stearate to be uniformly mixed, and the dripping pills are prepared to be orally taken. The plant stem cell composition can stimulate the immune system, eliminate variant cells and tumors, prevent and treat cardiovascular and cerebrovascular diseases, awaken self-repairing ability and immunity by a few drops, reduce the incidence of sudden death and advanced cancer caused by infarction when used in an early period, prolong the life of a patient and maintain the life health.
Description
Technical Field
The invention relates to a plant stem cell composition for dissolving thrombus and eliminating cancerated cells and tumors, belonging to the technical field of application of plant stem cells in treating cancers.
Background
Cancer is one of the diseases that accounts for the greatest proportion of the causes of death among modern people, and normal cells are transformed into cancer cells due to gene mutations for various reasons, resulting in malignant tumors that do not follow normal cell differentiation and growth morphology. The existing methods for treating malignant tumor cancer mainly comprise three methods, including surgery, radiotherapy and chemotherapy, the surgery has the problems of great side effect, incapability of preventing metastasis, extremely high cost and increased economic burden of patients; radiotherapy is suitable for acute inflammatory diseases, positive or malignant tumors, endocrine dysfunction, allergic diseases and the like, is generally effectively used for malignant tumors consisting of rapidly dividing cells, can cause the weakening or loss of the function of normal tissues, can generate skin diseases at the treatment part after treatment, can cause serious side effects such as intelligent development delay or bone development disorder and the like for children with ongoing organ development, and has the problems of bitter pain of patients in the treatment process. Although chemotherapy is widely used to disturb the replication or metabolism of cancer cells, anticancer agents have side effects of acting not only on cancer cells but also exerting their toxicity to normal cells of patients. Most of the side effects of chemotherapy require hospitalization in severe cases or require the administration of analgesics for the treatment of pain, which increases patient suffering. Therefore, many studies have been made on the development of novel drugs and agents having anticancer activity capable of inhibiting the growth of cancer cells and killing cancer cells, and in particular, studies have been focused on the development of anticancer substances in natural products having less side effects. The present inventors have made extensive efforts to develop natural-derived anticancer compositions that can minimize the side effects of conventional anticancer agents and act on the mechanism of cancer progression to express excellent anticancer activity, and as a result, have finally confirmed that cancer cell killing activity can be expressed from homogeneous cell lines including camptotheca acuminata, vinca rosea, taxus chinensis, and oldenlandia diffusa, their disrupted products, their extracts, and their culture solutions.
Disclosure of Invention
The invention aims to provide a plant stem cell composition which can minimize the side effect of the existing cancer therapeutic agent, has the activity of preventing and treating cancers and is derived from natural substances so as to solve the problems of great toxic and side effect, pain increase of patients, high cost and the like.
The plant stem cell composition for dissolving thrombus, eliminating cancerated cell and tumor includes camptotheca acuminata, catharanthus roseus, taxus chinensis and oldenlandia diffusa as raw material, and its cambium is induced, and its morphological characteristics are that it uses a large amount of vacuoles as morphological characteristics, and any one or more of its broken matter, its extract and its culture solution are in undifferentiated state.
The composition comprises, by weight, 10-15% of camptotheca acuminata, 5-20% of catharanthus roseus, 20-50% of taxus chinensis, 10-30% of oldenlandia diffusa and auxiliary materials. The camptotheca acuminata has the effects of resisting cancer, clearing heat and killing insects, and the camptothecine contained in the camptotheca acuminata is a plant anticancer drug and can be used for treating gastric cancer, colon cancer, rectal cancer, bladder cancer, chronic myelocytic leukemia, acute lymphocytic leukemia and the like; catharanthus roseus is a plant of Apocynaceae, has a plurality of medicinal effects of relieving pain, diminishing inflammation, soothing the nerves, relaxing bowels, inducing diuresis and the like, also has a good treatment effect on malignant tumors and leukemia problems, and generally can play a certain role in inhibiting the recovery process of leukemia and tumor diseases; paclitaxel extracted from bark and leaves of Taxus chinensis has good therapeutic effect on various cancers of late stage; the oldenlandia diffusa has the functions of clearing away heat and toxic materials, promoting blood circulation and inducing diuresis, and the oldenlandia diffusa also contains polysaccharide components, so that the oldenlandia diffusa can help to eliminate free radicals in a body, enhance the immunity of a human body, and play a role in inhibiting the growth of tumor cells and preventing and resisting cancers.
The plant stem cell composition auxiliary material is starch, ethanol or distilled water, and the composition is formed into a mixture by adding starch.
The plant stem cell composition also has the following characteristics: it exists as a single cell during suspension culture; lower sensitivity to shear stress in the bioreactor compared to cell lines from tissues other than the ginseng cambium; has a higher growth rate and can be stably cultured as compared with cell lines derived from tissues other than ginseng type-forming layers.
Adding ethanol or distilled water as adjuvant as moisturizer, stirring the composition until uniform, making into soft preparation, such as dripping pill, sieving, filtering to obtain granule, oven drying, and making into dripping pill.
The mesh of the prepared dripping pill is 50-100 meshes.
The water content of the dried granules of the composition prepared into the dripping pill is 1-8%.
The temperature of the dryer for drying the particles is kept between 30 and 120 ℃.
The plant stem cell composition for dissolving thrombus and eliminating cancerated cells and tumors is prepared by taking camptotheca acuminata, catharanthus roseus, taxus chinensis and oldenlandia diffusa which have anticancer plant elements as raw materials, inducing cambium or procambium containing tissues of plants, culturing the obtained cambium or procambium containing tissues, inducing the cambium or procambium to proliferate to form a layer or procambium, and inducing an amorphous callus layer to proliferate from other tissues except the cambium or procambium; collecting cell line from formation layer or original formation layer, collecting crushed material, extract and culture solution thereof, adding starch, ethanol or distilled water, stirring, and making into beverage, or filtering with screen mesh to obtain granule, oven drying, and making into dripping pill. The plant stem cell composition can dissolve embolism substances on blood and blood vessels, particularly cysteine, achieve the effect of melting ice by hot water, stimulate an immune system to eliminate variant cells and tumors, distinguish medicines from a method of softening blood, treating cancer by operation and radiotherapy and chemotherapy, play a role in preventing and treating cancer, and prevent infarction, sudden death or late cancer incidence by early administration, thereby prolonging the life of a patient and maintaining the life health.
Detailed Description
Example 1: selecting 150g of camptotheca acuminata, 50g of catharanthus roseus, 200g of taxus chinensis and 100g of oldenlandia diffusa, preferentially grinding roots into powder, soaking the powder in a solvent for a period of time, wherein the solvent is 100mg/L of an antioxidant, then pretreating the plants for 24 hours by using a mixed solution of organic bactericides of 5% of organic sulfur (such as mancozeb), 3% of trichloromethionyl (such as captan) instead of chlorothalonil and 0.1% of amitraz-guanidine cephalosporin sodium, and then repeatedly washing the plants for 40 minutes by using tap water so as to remove phenolic compounds and residual chemical substances. Then, the plants were surface sterilized in 70% ethanol for 2 minutes, 30% hydrogen peroxide for 10 minutes, and then washed 3-4 times with water. Thus, the procambium and cambium were separated, the division of cells from the procambium and cambium was visually observed, and after 20 days of culture, amorphous callus formed by dedifferentiation began to be induced from the layer consisting of phloem, cortex and epidermis. However, during the whole culture process, no cell division occurs in the xylem, and thus the formation layer is naturally separated from the xylem. After culturing for 30 days, the tissue begins to be divided into a formation layer and an upper layer containing phloem, namely an amorphous callus layer, and after the tissue is completely and naturally divided into two layers, the layers are respectively cultured in different culture dishes to be proliferated and form a uniform cell layer, the cambium is induced, any one or more of a crushed product, an extract and a culture solution thereof is taken, 100g of starch is added and mixed, ethanol or distilled water is added as a wetting agent and stirred until the mixture is uniform, a soft material or a drink is prepared, for example, the soft material or the drink is prepared, particles can be filtered out by a sieve with 50 meshes and added with sodium stearate and dried by a dryer, the water content of the dried particles is 1-8 percent, and the temperature of the dried particles by the dryer is kept between 30 and 120 ℃. The using method comprises the following steps: the oral liquid is administered orally at 5-10 drops per day. The dripping pill is orally administered 2 times a day, 3-5 granules each time.
Example 2: the method is the same as that of example 1 except that the plants of camptotheca acuminata 100g, catharanthus roseus 200g, taxus chinensis 500g and oldenlandia diffusa 200g are selected.
Example 3: the method is the same as example 1 except that 120g of camptotheca acuminata, 150g of catharanthus roseus, 400g of taxus chinensis and 130g of oldenlandia diffusa are selected as plants.
Claims (8)
1. A plant stem cell composition for dissolving thrombus and eliminating cancerated cells and tumors is characterized in that: the composition is prepared from Camptotheca acuminata, Catharanthus roseus, Taxus chinensis, and Hedyotis diffusa, and has cambium induced, large amount of vacuole as morphological feature, and one or more of its broken product, its extract and its culture solution, which are in undifferentiated state.
2. The plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 1, which is characterized in that: the composition comprises, by weight, 10-15% of camptotheca acuminata, 5-20% of catharanthus roseus, 20-50% of taxus chinensis, 10-30% of oldenlandia diffusa and auxiliary materials.
3. The plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 1, which is characterized in that: the composition adjuvant is starch, ethanol or distilled water.
4. The plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 1, which is characterized in that: the plant stem cell composition also has the following characteristics: it exists as a single cell during suspension culture; lower sensitivity to shear stress under the bioreactor compared to cell lines from tissues other than the ginseng-like layer; has a higher growth rate and can be stably cultured as compared with cell lines derived from tissues other than ginseng type-forming layers.
5. The plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 1, which is characterized in that: the composition can be mixed with ethanol or distilled water as humectant, and stirred to obtain soft preparation or beverage, such as dripping pill, filtering with screen to obtain granules, adding sodium stearate, oven drying, and making into dripping pill.
6. The preparation method of the plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 5 is characterized in that: the mesh of the prepared dripping pill is 50-100 meshes.
7. The preparation method of the plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 5 is characterized in that: the water content of the dried granules is 1-8%.
8. The preparation method of the plant stem cell composition for dissolving thrombus, eliminating cancerated cells and tumors according to claim 5 is characterized in that: the temperature of the dryer for drying the particles is kept between 30 and 120 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010041360.1A CN111135219A (en) | 2020-01-15 | 2020-01-15 | Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010041360.1A CN111135219A (en) | 2020-01-15 | 2020-01-15 | Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111135219A true CN111135219A (en) | 2020-05-12 |
Family
ID=70525130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010041360.1A Pending CN111135219A (en) | 2020-01-15 | 2020-01-15 | Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111135219A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101842112A (en) * | 2007-10-10 | 2010-09-22 | 云火公司 | Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium |
| CN102209550A (en) * | 2008-11-06 | 2011-10-05 | 云火公司 | Composition for preventing or treating cancer containing as active ingredient plant stem cell line derived from ginseng cambium including wild ginseng or ginseng |
-
2020
- 2020-01-15 CN CN202010041360.1A patent/CN111135219A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101842112A (en) * | 2007-10-10 | 2010-09-22 | 云火公司 | Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium |
| CN102209550A (en) * | 2008-11-06 | 2011-10-05 | 云火公司 | Composition for preventing or treating cancer containing as active ingredient plant stem cell line derived from ginseng cambium including wild ginseng or ginseng |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103355663B (en) | Food formula for nourishing, maintaining and repairing various stem cells and preparation method thereof | |
| KR101764729B1 (en) | Method of manufacturing a fine dust detox drink composition and itself | |
| KR101595426B1 (en) | Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent | |
| US12465626B2 (en) | Traditional Chinese medicine composition with improving cognition effect, preparation method thereof and traditional Chinese medicine preparation | |
| CN113841894B (en) | Preparation method of lycium ruthenicum anthocyanin extract and freeze-dried powder and application of lycium ruthenicum anthocyanin extract and freeze-dried powder in antioxidant and anti-aging products | |
| CN101254011B (en) | Corn capillament drink and method of preparing the same | |
| CN103239706A (en) | Earthworm protein for reducing blood glucose, improving microcirculation and eliminating diabetic complication and application thereof | |
| CN117981877A (en) | Anti-alcohol liver-protecting composition and application thereof | |
| CN103263660A (en) | Earthworm protein for reducing blood sugar and blood pressure and eliminating diabetic complications and application pf earthworm protein | |
| CN111135219A (en) | Plant stem cell composition for dissolving thrombus and eliminating cancerated cell and tumor | |
| CN101468155A (en) | Chinese medicinal composition for treating dementia, as well as preparation method, preparation and use thereof | |
| CN103932172B (en) | A kind of Chinese caterpillar fungus health product and preparation method thereof | |
| CN108185239B (en) | Blackberry and sea-buckthorn compound health-care stock solution and preparation method thereof | |
| CN107028065B (en) | Method for increasing carotenoid content in wolfberry extracting solution and preparation method of wolfberry fermented beverage | |
| CN110651939A (en) | Composition suitable for gout population | |
| CN108186921B (en) | An antitumor selenium-containing Chinese medicinal composition and its preparation method | |
| KR101104269B1 (en) | Pharmaceutical composition for preventing and treating cancer comprising iris extract | |
| CN114366775A (en) | Eye-protecting nutrient solution | |
| CN106701595B (en) | Method for rapidly domesticating wild meat ganoderma lucidum | |
| CN106350413A (en) | Compound health wine and preparation method thereof | |
| CN111772185A (en) | Plant health-care composition and preparation method thereof | |
| CN111513157A (en) | Health tea containing medlar and cassia seed and preparation method thereof | |
| CN111955570A (en) | Ginseng white ganoderma lucidum tea capable of enhancing immunity and preventing tumors and production process thereof | |
| KR20220063768A (en) | Feed additive composition that can increase the immune activity and resistance of shrimp | |
| KR101704481B1 (en) | Composition for slimming containing pharbitidis seed extract or anthriscs aemula schisch extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200512 |